SYDNEY MURRAY: Open Payments
NPI 1831782028 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 55 payments from 7 companies in 2025. Trend: 2023 $553 · 2024 $1,222 · 2025 $954
Food & beverage: $855Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $387 |
| ABBVIE INC. | 30 | $348 |
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Organon LLC | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $22 |
| UCB, Inc. | 1 | $15 |
Products named: TREMFYA, RINVOQ, SKYRIZI, COSENTYX, Rhapsido, INJECTAFER, NEMLUVIO, Bimzelx.
Industry payments across PA — which companies pay providers there.
